Amphotericin B: Difference between revisions
(Replace manual dosing with dynamic SMW tables (Adult + Pediatric)) |
(Restore original dosing content alongside dynamic SMW tables) |
||
| Line 7: | Line 7: | ||
==Adult Dosing== | ==Adult Dosing== | ||
''Dosing is '''NOT''' interchangeable between different formulations of amphotericin B due to significant variations in pharmacokinetics. Call your institution's pharmacy (or ID) if unsure about correct dose. | |||
===Indications by Disease=== | ===Indications by Disease=== | ||
{{#ask: [[Has DrugName::Amphotericin B]] [[Has Population::Adult]] | {{#ask: [[Has DrugName::Amphotericin B]] [[Has Population::Adult]] | ||
|?Treats disease=Disease | |?Treats disease=Disease | ||
|?Has Dose=Dose | |?Has Dose=Dose | ||
|?Has Context=Context | |?Has Context=Context | ||
|format=table | |format=table | ||
|limit=50 | |limit=50 | ||
|mainlabel=- | |mainlabel=- | ||
|headers=show | |headers=show | ||
|sort=Treats disease | |sort=Treats disease | ||
}} | }} | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Indications by Disease=== | ===Indications by Disease=== | ||
{{#ask: [[Has DrugName::Amphotericin B]] [[Has Population::Pediatric]] | {{#ask: [[Has DrugName::Amphotericin B]] [[Has Population::Pediatric]] | ||
|?Treats disease=Disease | |?Treats disease=Disease | ||
|?Has Dose=Dose | |?Has Dose=Dose | ||
|?Has Context=Context | |?Has Context=Context | ||
|format=table | |format=table | ||
|limit=50 | |limit=50 | ||
|mainlabel=- | |mainlabel=- | ||
|headers=show | |headers=show | ||
|sort=Treats disease | |sort=Treats disease | ||
}} | }} | ||
Latest revision as of 02:39, 20 March 2026
Administration
- Type: Antifungal
- Dosage Forms: powder for injection
- Dosage Strengths: 50mg/vial
- Routes of Administration: IV
- Common Trade Names: AmBisome, Fungizone "ampho-terrible"
Adult Dosing
Dosing is NOT interchangeable between different formulations of amphotericin B due to significant variations in pharmacokinetics. Call your institution's pharmacy (or ID) if unsure about correct dose.
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Cryptococcosis | 0.7-1mg/kg IV q24hrs | Meningitis not AIDS with Flucytosine x 4 weeks |
| Cryptococcosis | 0.7-1mg/kg IV q24hrs | Meningitis with AIDS with Flucytosine x 2 weeks |
Pediatric Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Cryptococcosis | 0.7-1mg/kg IV daily x 2-4 weeks | Pediatric Meningitis |
Special Populations
- Pregnancy Rating: B
- Lactation risk: Infant risk cannot be ruled out
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Nephrotoxicity/renal failure, hemorrhagic cystitis
- Anaphylaxis
- Cardiac arrest
Common
- Hypokalemia, hypomagnesemia, hyperglycemia (check BMP at least daily)
- Rigors
- Nausea/vomiting, diarrhea
- Anemia
- Rash
- Dyspnea
- Insomnia
Pharmacology
- Half-life: Depends on formulation, 1-14 days
- Metabolism: unknown
- Excretion: urine
Mechanism of Action
- Binds to ergosterol in fungal cell membranes→ intracellular contents leak out→ cell dies
Comments
Amphotericin B is an antifungal agent used to treat severe or disseminated fungal infections (e.g. invasive aspergillosis, cryptoccoccal meningitis, coccidioidomycosis, mucormycosis, fungemia in neutropenic patients). It comes in several formulations; conventional, cholesteryl sulfate complex, lipid complex, and liposomal. It is usually reserved for serious infection due to significant associated toxicities, though the newer formulations tend to be better tolerated.